# The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis

> **NCT00330135** · PHASE3 · TERMINATED · sponsor: **Daiichi Sankyo** · enrollment: 85 (actual)

## Conditions studied

- Symptomatic Hip Osteoarthritis

## Interventions

- **DRUG:** Sodium hyaluronate
- **DRUG:** placebo injection

## Key facts

- **NCT ID:** NCT00330135
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2008-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00330135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00330135, "The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00330135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*